Opinion/decision on a Paediatric investigation plan (PIP): Reblozyl, Luspatercept, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Haematology-Hemostaseology, PIP number:

Opinion/decision on a Paediatric investigation plan (PIP): Reblozyl, Luspatercept, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Haematology-Hemostaseology, PIP number: P/0441/2023